INSY

Insys Therapeutics, Inc. Press Releases

$38.78
*  
0.52
1.32%
Get INSY Alerts
*Delayed - data as of Sep. 30, 2014  -  Find a broker to begin trading INSY now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Insys Therapeutics Receives FDA Orphan Drug Designation for Its Pharmaceutical Cannabidiol as a Potential Treatment for Glioma
9/29/2014 7:00:00 AM - Market Wire

Insys Therapeutics, Inc. Named Arizona Bioscience Company of the Year
9/3/2014 8:00:00 AM - Business Wire

Insys Therapeutics to Present at Morgan Stanley Global Healthcare Conference 2014
8/26/2014 7:00:00 AM - Market Wire

Insys Therapeutics Receives FDA Orphan Drug Designation for Its Pharmaceutical Cannabidiol as a Potential Treatment for Glioblastoma Multiforme
8/25/2014 7:00:00 AM - Market Wire

Insys Therapeutics Submits NDA for Its New Oral Formulation of Dronabinol
8/12/2014 7:32:00 AM - Market Wire

Insys Therapeutics Reports Second Quarter 2014 Results
8/12/2014 6:50:00 AM - Market Wire

Insys Therapeutics to Report Second Quarter 2014 Results
7/29/2014 8:00:00 AM - Market Wire

SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against INSYS Therapeutics, Inc. and Certain Officers - INSY
7/11/2014 4:17:00 PM - Market Wire

INSYS 96 HOUR DEADLINE ALERT: Approximately 96 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors of Deadline in Securities Class Action Lawsuit Against INSYS Therapeutics, Inc. - INSY
7/10/2014 10:00:00 PM - Market Wire

INSYS Therapeutics Shareholder Alert: Former SEC Attorney Willie Briscoe and Powers Taylor Investigate Possible Breaches of Fiduciary Duty by Officers and Directors
7/8/2014 11:36:00 AM - Business Wire

Insys Therapeutics Updates Timing of NDA for Dronabinol Oral Solution
7/8/2014 7:00:00 AM - Market Wire

Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In INSYS Therapeutics, Inc. (INSY) To Contact The Firm
7/4/2014 1:17:00 PM - PR Newswire